Who owns ACHILLES THERAPEUTICS PLC?
- Ticker: ACHL
- CUSIP Number: 00449l102
Tip: Access positions for across all investors
Analyze quarterly positions in Achilles Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Achilles Therapeutics stock
Who bought or sold ACHILLES THERAPEUTICS PLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Syncona Portfolio | 11M | $14M | 0% | Mar 2024 |
|
| Fcpm Iii Services B.v. | 2.4M | $3.0M | 0% | Mar 2024 |
|
| Redmile Group | 1.6M | $2.0M | 0% | Mar 2024 |
|
| Ikarian Capital | 1.4M | $1.8M | 100% | Mar 2024 |
|
| Baker Bros. Advisors | 1.2M | $1.5M | -43% | Mar 2024 |
|
| Artal Group | 755k | $944k | -67% | Mar 2024 |
|
| Boothbay Fund Management | 421k | $526k | 100% | Mar 2024 |
|
| Acadian Asset Management | 281k | $350k | 100% | Mar 2024 |
|
| Citadel Advisors | 105k | $131k | -3% | Mar 2024 |
|
| Forefront Analytics | 95k | $119k | 22% | Mar 2024 |
|
| Hrt Financial | 37k | $46k | 100% | Mar 2024 |
|
| Geode Capital Management | 22k | $27k | 0% | Mar 2024 |
|
| Virtu Financial | 21k | $26k | -47% | Mar 2024 |
|
| Millennium Management | 19k | $24k | -38% | Mar 2024 |
|
| Vontobel Holding | 19k | $24k | 100% | Mar 2024 |
|
| Morgan Stanley | 18k | $23k | -64% | Mar 2024 |
|
| Two Sigma Advisers | 18k | $22k | 100% | Mar 2024 |
|
| Two Sigma Securities | 16k | $20k | 12% | Mar 2024 |
|
| XTX Topco | 15k | $19k | -28% | Mar 2024 |
|
| Two Sigma Investments | 12k | $15k | 100% | Mar 2024 |
|
| Resources Investment Advisors | 11k | $13k | 100% | Mar 2024 |
|
| Brave Asset Management | 10k | $13k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 3.5k | $4.4k | 100% | Mar 2024 |
|
| Global Retirement Partners | 2.0k | $2.5k | -33% | Mar 2024 |
|
| Bank of America Corporation | 1.1k | $1.4k | -95% | Mar 2024 |
|
| ICA Group Wealth Management | 400.00 | $500.000000 | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 137.00 | $171.003400 | -86% | Mar 2024 |
|
| Qube Research & Technologies | 73.00 | $91.001800 | 0% | Mar 2024 |
|
| Royal Bank of Canada | 35.00 | $0 | 0% | Mar 2024 |
|
Who sold out of Achilles Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Point72 Asset Management | Dec 2023 | 1.4M | $1.3M |
| Coppell Advisory Solutions | Sep 2023 | 1.0k | $5.6k |